These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17395863)

  • 41. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patterns of cerebral ischemia in children with moyamoya.
    Rafay MF; Armstrong D; Dirks P; MacGregor DL; deVeber G
    Pediatr Neurol; 2015 Jan; 52(1):65-72. PubMed ID: 25459363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moyamoya disease in China: its clinical features and outcomes.
    Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
    Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Moyamoya disease: Diagnosis, clinical features, evolution and treatment in 10 patients].
    Blanc C; Janoura S; Pallot C; Mettey L; Bardin F; Ricolfi F; Chavent A; Osseby GV; Giroud M; Béjot Y
    Rev Neurol (Paris); 2015 Jan; 171(1):58-64. PubMed ID: 25555852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
    Muraoka S; Araki Y; Kondo G; Kurimoto M; Shiba Y; Uda K; Ota S; Okamoto S; Wakabayashi T
    World Neurosurg; 2018 May; 113():e190-e199. PubMed ID: 29432946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease: a prospective T2*-weighted MRI study.
    Kuroda S; Kashiwazaki D; Ishikawa T; Nakayama N; Houkin K
    Stroke; 2013 Feb; 44(2):516-8. PubMed ID: 23223508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
    Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
    Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of akin moyamoya disease associated with type-I diabetes mellitus managed by extracranial-intracranial bypass].
    Akamatsu Y; Fujimura M; Sakata H; Endo H; Itabashi R; Tominaga T
    No Shinkei Geka; 2015 Mar; 43(3):227-33. PubMed ID: 25748808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of surgical revascularization on cerebral oxygen metabolism in patients with Moyamoya disease: an 15O-gas positron emission tomographic study.
    Kuroda S; Kashiwazaki D; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2014 Sep; 45(9):2717-21. PubMed ID: 25116870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term Outcome over Five Years after Surgical Revascularization in Adult Moyamoya Disease].
    Ozaki S; Inoue A; Miyazaki H; Onoue S; Ichikawa H; Fukumoto S; Iwata S; Ohue S; Kohno K
    No Shinkei Geka; 2016 Oct; 44(10):823-834. PubMed ID: 27729602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical course and outcome in French adults with Moyamoya disease].
    Calviere L; Catalaa I; Frugier CG; Viguier A; Albucher JF; Delisle MB; Larrue V
    Rev Neurol (Paris); 2009; 165(8-9):709-17. PubMed ID: 19147166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adult moyamoya after revascularization.
    Gross BA; Du R
    Acta Neurochir (Wien); 2013 Feb; 155(2):247-54. PubMed ID: 23108563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series.
    Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G
    World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of adult moyamoya disease showing fulminant clinical course associated with progression from unilateral to bilateral involvement].
    Fujiwara F; Yamada H; Hayashi S; Tamaki N
    No Shinkei Geka; 1997 Jan; 25(1):79-84. PubMed ID: 8990473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experience of 97 patients with moyamoya disease: long-term follow-up at a single center].
    Liu XJ; Zhang D; Wang S; Zhao YL; Wang R; Zhao JZ
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):604-7. PubMed ID: 22800948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis.
    Qin Y; Ogawa T; Fujii S; Shinohara Y; Kitao S; Miyoshi F; Takasugi M; Watanabe T; Kaminou T
    Acta Radiol; 2015 Mar; 56(3):329-38. PubMed ID: 24558166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible occlusion of donor vessel caused by mouth opening after superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya patients.
    Katsuta T; Abe H; Miki K; Inoue T
    J Neurosurg; 2015 Sep; 123(3):670-5. PubMed ID: 25909570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India.
    Sundaram S; Sylaja PN; Menon G; Sudhir J; Jayadevan ER; Sukumaran S; Sreedharan SE; Sarma S
    J Neurol Sci; 2014 Jan; 336(1-2):99-102. PubMed ID: 24183032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult moyamoya angiopathy in Bourgogne-Franche-Comté: Epidemiology, diagnosis and management.
    Brandicourt P; Blanc C; Bonnet L; Béjot Y; Ricolfi F; Drouet C; Moulin T; Thines L
    Rev Neurol (Paris); 2019 Apr; 175(4):247-251. PubMed ID: 30447881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.